Semenis Biotechnologie - 500 Beiträge pro Seite

[TUBE77]

Servus!
Ich hab den Tip bekommen, dass Semenis marktführer in der Samenproduktion ist. Sie ist im Moment auf ihrem Tiefststand, soll aber demnächst durch Meldungen wieder explodieren.
Habt ihr vielleicht weitere Informationen?

Bis denn in diesen harten Zeiten

[gholzbauer]

Profile:
Seminis develops, produces & markets vegetable and fruit seeds designed to reduce the need for chemicals and spoliage, increase crop yield, offer longer shelf life & create tastier foods with better nutritional content. For the 9 months ended 6/30/00, revenues fell 6% to $382.2M. Netloss applic. to Common before extra. item totalled $24.6M, up from $5.4M. Results reflect unfavourable horticultural indusrty, currency fluctuation and higher SG&A expenses.

Analysten erwarten für 2000 und 2001 Verluste.
http://www.siliconinvestor.com/research/eps.gsp?s=SMNS
Allerdings hoher Buchwert von fast 8$ pro Aktie, der wiederum durch Abschreibungen sehr schnell sinken könnte.
KUV unter 20%, das wäre billig.



Antitrust-Prozeß mit evtl. saftiger Strafe:

U.S. sues Seminis venture over biotech tomato seeds
WASHINGTON, Sept 15 (Reuters) - The U.S. government filed an antitrust lawsuit Friday to force two companies that sell bio-engineered seeds for tomatoes that stay fresh longer to allow another competitor to develop the same kind of seeds.

The civil lawsuit was filed in federal court in Tucson against Seminis Vegetable Seeds Inc (NASDAQ: SMNS) and LSL Biotechnologies Inc., the Justice Department said in a statement.

The two companies formed a joint venture, LSL Plant Science, to develop seeds that would produce tomatoes with a longer shelf life. That is a highly desired quality that means U.S. farmers can grow vine-ripened tomatoes during the winter months and ship them to market before spoiling.

But the joint venture agreement prohibited a competitor, Hazera Quality Seeds Inc., from competing to develop and sell similar seeds, the Justice Department said.

"Competition to innovate spurs companies to offer consumers more choices and higher quality products at better prices," said Joel Klein, the assistant attorney general who heads the antitrust division.

"This agreement deprives American farmers and consumers of the full benefits of that competition," he added.

American consumers spend nearly $4 billion a year on fresh tomatoes.

During winter months, most tomatoes grown in southern U.S. states are picked while green, shipped north to markets and treated with gas until they redden. Bio-engineered tomato seeds offering longer shelf life -- which are already being grown in Mexico -- can fully ripen on the vine before being shipped.

LSL Biotechnologies is based in Tucson. Seminis, which is headquartered in Saticoy, California, is a majority owned unit of Mexico`s Savia (NYSE: VAI) conglomerate.




Insgesamt erscheinen mir die Risiken sehr hoch zu sein, und Food-Biotech ist nicht nur bei Verbrauchern, sondern auch an der Börse mega-out. Ich glaube nicht, daß sich das schnell ändert. Man könnte vielleicht auf ein Rückkaufangebot des Großaktionärs Savia spekulieren.

[gholzbauer]

Da sind sie also, die ersten 36 Mio. $ Abschreibungen, die den Buchwert reduzieren.


Seminis warns of lower-than-expected Q4 sales
OXNARD, Calif., Oct. 19 (Reuters) - Vegetable seed marketer Seminis Inc.(NASDAQ: SMNS) warned on Thursday that it expects its fourth-quarter loss to widen from a year earlier, saying unfavorable market conditions shaved sales by about 24 percent.

As a result of lower sales and noncash charges related to excess inventory, the company said will report a significantly higher loss as compared to last fiscal year.

The Oxnard, Calif.-based company attributed the decrease in sales primarily to unfavorable market conditions in the NAFTA region, non-core sales of divested assets and the weakness of the euro in relation to the dollar.

Seminis expects to take a noncash charge of $36 million -- $29 million in inventory excess reserves and $7 million in inventory write-offs, primarily related with non-core operations in Europe.

As a result of the lower than expected sales and the additional reserves, the company said will not be in compliance with certain financial covenants under its loan agreement starting as of September 30, 2000. Seminis said it is negotiating with its banks to formally amend and modify the financial covenants for future periods.